Involvement of intracellular Ca
S KELETAL MUSCLE is a target for the action of anabolic steroids (1) . These hormones affect cell growth and development and are known to produce their effects by binding to intracellular androgen receptors. Upon ligand binding, the hormone-receptor complex translocates to the nucleus and binds to specific DNA sequences called hormone response elements. The binding of the complex to DNA results in transcription of specific genes (2, 3) . However, several nongenomic actions of androgens on rat osteoblasts (4), macrophages (5) , and skeletal muscle cells (6) have been reported. Common to these early effects is the fast intracellular calcium increase, activation of Ca 2ϩ -dependent pathways, and second messenger cascades (7) . In skeletal muscle cells, intracellular calcium regulates contraction, but alternative roles for calcium in muscle cells, as a regulator of gene expression, have been proposed (8, 9) . These effects have been associated with functionally distinct exogenous stimuli as well as to coexistence of multiple Ca 2ϩ release mechanisms within a single cell. In skeletal muscle cells the association between intracellular calcium increases and induction of specific genomic responses is poorly understood. However, these responses could be involved in the generation of different patterns of calcium signals (10, 11) and also in the interaction of different Ca 2ϩ -dependent pathways (12) . We have previously shown that in skeletal muscle cells, both aldosterone and testosterone produce rapid intracellular calcium increases (6) involving calcium release from inositol 1,4,5-trisphosphate (IP 3 )-sensitive stores. These calcium transients were not modified by the use of spironolactone or cyproterone, inhibitors of intracellular mineralocorticoid and androgen receptors, respectively. Calcium signals elicited by steroid hormones, via an increase in intracellular IP 3 and associated with increased nucleoplasmic calcium, may have an important role in the regulation of unknown process in the muscle cell. An interesting route of convergence could correspond to ERK1/2. ERK1/2 are one class of MAPK and have been assigned an important role in the intracellular signal pathway that leads to division, growth, and/or differentiation in several cell types (13) . This is mainly due to their capacity to phosphorylate a variety of transcription factors and other intracellular signal transduction proteins (14) . Full activation of these enzymes requires dual phosphorylation of threonine and tyrosine residues (13, 14) . The skeletal muscle ERK1/2 are activated by exercise (15) , hormones (16, 17) , growth factors (18) , and diverse stress stimuli (19) . Membrane receptors, intracellular second messengers, and localized changes in the intracellular calcium levels have been postulated to have a role in these effects. It is known that in skeletal muscle, androgen steroids can produce hypertrophy (20, 21) ; on the other hand, a role for calcium in muscle hypertrophy has been proposed (10) . Thus, steroid hormones could activate rapid calcium increases as well as the MAPK cascades previous to nuclear events (22, 23) . Several steroid hormones have been shown to stimulate ERK1/2 phosphorylation; it has been described that in breast cancer cells, estrogens can induce rapid activation of a MAPK cascade Abbreviations: BAPTA-AM, 1,2-Bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acid-AM; CRE, cAMP response element; CREB, CRE-binding protein; GDP␤S, guanosine 5Ј-O-(2-thiodiphosphate); IP 3 , inositol, 1,4,5-trisphosphate; MEK, MAPK kinase; PLC, phospholipase C; PTX, pertussis toxin; T-BSA, testosterone bound to albumin; TBST, Trisbuffered saline containing 0.1% Tween 20. independent of both transcription and protein synthesis, but require mobilization of intracellular calcium (24) . Moreover, it has been reported that estrogens can indirectly enhance the kinase activity of an estrogen receptor, which then activates MAPK via the Ras pathway (25) . In prostate cancer cells, dihydrotestosterone leads to a rapid and reversible activation of ERK1/2 via the androgen receptor (26) . In this work we describe a pathway of intracellular signaling that includes a G protein-linked membrane receptor, Ca 2ϩ released from intracellular stores through IP 3 receptors, and activation of the ERK phosphorylation cascade. This mechanism would be either parallel or previous to the traditional mode of action proposed for steroid hormones.
Materials and Methods

Chemical reagents
Testosterone, testosterone-BSA, cyproterone acetate (6-chloro-1␤,2␤-dihydro-17-hydroxy-3ЈH-cycloropropa[1,2]-pregna-1,4,6-triene-3,20-dioneacetate), nandrolone (4-estren-17␤-ol-3-one), 17␤-estradiol, progesterone, dexamethasone, U-73122, and luciferin were purchased from Sigma-Aldrich Corp. (St. Louis, MO). Fluo-3 acetoxymethylester (Fluo-3/AM) and 1,2-bis(2-aminophenoxy)ethane-N,N,NЈ,NЈ-tetraacetic acidacetoxymethylester (BAPTA-AM) were purchased from Molecular Probes (Eugene, OR). PD-98059, Bordetella pertussis toxin (PTX), guanosine 5Ј-O-(2-thiodiphosphate) (GDP␤S), and genistein were obtained from Calbiochem (La Jolla, CA). Xestospongin B was a gift from Dr. Jordi Molgò (Centre National de la Recherche Scientifique, Gif-surYvette, France). Antiphospho-ERK1/2 antibody was obtained from Cell Signaling Technology, Inc. (Beverly, MA). Total ERK1/2 and horseradish peroxidase-linked antirabbit IgG were purchased from New England Biolabs, Inc. (Beverly, MA). Enhanced chemiluminescence reagents and fluorescein isothiocyanate-conjugated goat antirabbit IgG were obtained from Pierce Chemical Co. (Rockford, IL). Antiandrogen receptor antibody (C-19) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The plasmids encoding dominant negative Ha-Ras N17 , dominant negative MAPK kinase (MEK), pON249 in which ␤-galactosidase is expressed from a constitutive cytomegalovirus promoter, and the reporter construct p-cAMP response element (CRE)-Luc were provided by Dr. Sergio Lavandero (Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile). Other reagents were of the analytical grade.
Cell cultures
Rat myotubes were cultured as reported previously (27) . Briefly, myoblasts were obtained from rat neonatal hind limbs, and the tissue was mechanically dispersed and then treated with 10% (wt/vol) collagenase for 15 min at 37 C under mild agitation. The suspension was filtered through a Nytex (Sartorius, Goettingen, Germany) membrane and spun down at low speed, preplating was used to partially eliminate fibroblasts, and finally, cells were plated onto dishes (60 mm) at a density of 1.2 ϫ 10 6 /dish. The culture medium was DMEM/F-12 without phenol red, 10% bovine serum, 2.5% fetal calf serum, 100 mg/liter penicillin, 50 mg/liter streptomycin, and 2.5 mg/liter amphotericin B. To eliminate remaining fibroblasts, 10 m cytosine arabinoside was added on the third day of culture for 24 h. The medium was then replaced with serum-free medium. Myotubes with an estimated purity of more than 90% were visible after the fifth day of culture. Unless indicated, we used 6-to 8-d-old cultures exhibiting a fairly homogeneous population of myotubes with central nuclei and measuring 200 -300 m long and 20 -40 m wide, corresponding to young, not fully differentiated cells.
Intracellular calcium measurement
Cytosolic calcium images were obtained from single noncontracting myotubes preloaded with Fluo-3-AM using an inverted confocal microscope (Axiovert 135M, LSM Microsystems, Carl Zeiss, New York, NY) or a fluorescence microscope (T041, Olympus Corp., New Hyde Park, NY) equipped with a cooled CCD camera and image acquisition system (MCD 600, Spectra Source Instruments, Westlake Village, CA).
Myotubes were washed three times with Krebs buffer [145 mm NaCl, 5 mm KCl, 2.6 mm CaCl 2 , 1 mm MgCl 2 , 10 mm HEPES-sodium, and 5.6 mm glucose (pH 7.4)] to remove serum and loaded with 5.4 m Fluo-3-AM (coming from a stock in 20% pluronic acid-dimethylsulfoxide) for 30 min at room temperature. After loading, myotubes were washed with the same buffer and used within 2 h. The cell-containing coverslips were mounted in a 1-ml capacity plastic chamber and placed in the microscope for fluorescence measurements after excitation with a 488-nm wavelength argon laser beam or filter system. Hormones were added directly to the medium, or the solution was fast changed in the chamber (1 sec). The fluorescent images were collected every 0.4 -2.0 sec for fast signals and were analyzed frame by frame with the image data acquisition program (MCD 600, Spectra-Source) of the equipment. An objective lens PlanApo ϫ40 (numerical aperture, 1.4) was generally used. In most of the acquisitions, the image dimension was 512 ϫ 120 pixels. The inhibitors were added during the dye incubation; times and concentrations are indicated in Results. To assess the role of G proteins, myotubes were incubated either with 1 g/ml PTX for 5 h or in a permeabilization solution [100 mm KCl, 20 mm NaCl, 5 mm MgSO 4 , 1 mm NaH 2 PO 4 , 25 mm NaHCO 3 , 3 mm EGTA, 1 mm CaCl 2 , 20 mm Tris-HCl (pH 7.4), 0.1% BSA, 1 mm ATP, 0.1% glucose, and 40 mg/ml saponin] for 5 min in the presence or absence of 100 nm GDP␤S, a nonhydrolyzable analog of GDP, before hormone stimulation. Intracellular calcium was expressed as a percentage of fluorescence intensity relative to basal fluorescence, which was stable for at least 5 min during resting conditions. The increase in fluorescence intensity is proportional to the rise in intracellular calcium level (28) .
Digital image processing
Elimination of out of focus fluorescence was performed by software. Both "no-neighbors" deconvolution algorithm and Castleman's point spread function theoretical model were used. Complementary to restoration methods, a procedure was created to segment the images. To section an image, an initial contour can be entered manually, and a recursive algorithm that adapts automatically to the region of interest (adaptable contour) can be applied (6) . To quantify fluorescence, the summed pixel intensity was calculated for the section delimited by a contour. As a way of increasing the efficiency of these data manipulations, action sequences were generated. To avoid possible interference in the fluorescence by changes in volume after exposure to steroids, the area of fluorescent cell was determined by image analysis using adaptive contour and then creating a binary mask, which was compared with a brightfield image.
Determination of IP 3 levels
IP 3 levels were determined as described previously (27) . Briefly, a crude rat cerebellum membrane preparation was obtained after homogenization in 50 mm Tris-HCl (pH 7.7), 1 mm EDTA, 2 mm ␤-mercaptoethanol, and centrifugation at 20,000 ϫ g for 15 min. This procedure was repeated three times, resuspending the final pellet in the same solution plus 0.3 m sucrose and freezing it at Ϫ80 C until use. The membrane preparation was calibrated for IP 3 
Immunocytochemistry
Intracellular androgen receptor was localized using indirect immunofluorescence. Myotubes (control and testosterone stimulated) were washed and then fixed with 100% methanol at Ϫ20 C for 20 min and treated with a blocking solution of 1% BSA in PBS for 30 min. Cells were incubated with the primary polyclonal antiintracellular androgen receptor antibody (1:100) overnight at 4 C. Later, myotubes were washed in PBS and incubated with fluorescein isothiocyanate-conjugated goat antirabbit IgG diluted 1:200 for 2 h at room temperature. Cells were washed, and Vectashield (Vector Laboratories, Inc., Burlingame, CA) was added to prevent bleaching. Myotubes were examined with a confocal microscope (135-M LSM Microsystems, Carl Zeiss). Controls were performed both without the primary antibody and by displacement with the antigenic peptide as a test for specificity.
ERK1/2 phosphorylation by steroids and Western blot
Myotubes were grown on 60-mm plates and serum-starved for 24 h before being exposed to steroids for various times, as indicated in Results and the figure legends. Cells were washed with ice-cold PBS and scraped off plates in 70 l harvesting lysis buffer [150 mm NaCl, 1 mm EGTA, 1% Nonidet P-40, 50 mm Tris-HCl (pH 7.4), 5 mm sodium orthovanadate, 20 mm NaF, 1 g/ml aprotinin, 1 m pepstatin, 20 m leupeptin, 1 mm benzamidine, and 0.2 mm 4-(2-aminoethyl)benzene sulfonyl fluoride]. They were then sonicated and subjected to centrifugation at 15,000 ϫ g for 20 min. Supernatants were removed and divided into portions for ERK1/2 determination and protein assay. Equal amounts of proteins (20 g ) were denatured at 100 C in 30% glycerol, 8% sodium dodecyl sulfate, 10% 2-mercaptoethanol, 25 mm Tris-HCl (pH 6.8), and 0.1% bromophenol blue; resolved by 10% SDS-PAGE; and transferred to 0.22-m pore nitrocellulose filters. Nonspecific staining was blocked with Tris-buffered saline containing 0.1% Tween 20 (TBST) and 5% nonfat dry milk at room temperature for 1 h. Nitrocellulose membranes were incubated overnight at 4 C with primary antibody raised against phosphorylated ERK1/2 (1:1000). Next, the membranes were washed three times in TBST, incubated with peroxidase-conjugated secondary antibody (1:2000) for 2 h at room temperature, and washed three additional times in TBST. Enhanced chemiluminescence techniques were used to visualize the immunoblots according to the manufacturer's protocol. The membranes were stripped according to conventional methods and immunoblotted with pan-ERK (phosphorylated and nonphosphorylated ERK1/2) for total ERK1/2 protein. Digitized images of the immunoblots were used for densitometric measurements with ScionImage software (NIH, Bethesda, MD). Relative enzyme activation was determined by normalization of densities image to that of the total ERK1/2 from the same membrane.
Transient transfection of primary myotubes
Cells were grown in 60-mm dishes to 60% confluence. Before transfection, the cells were washed to remove serum and were transiently transfected with either empty vectors or dominant negative Ras, MEK, or pON249 (2-4 g) using Lipofectamine (Invitrogen Life Technologies, Inc., Gaithersburg, MD) following the manufacturer's instructions. A single plate of transfected cells was then used to set-up the experimental cultures required for each assay, ensuring equal transfection efficiencies between different treatments, and cells were cultured for an additional 24 h before treatment with androgens. For reporter gene assays, myotubes were cotransfected with pCRE-Luc (2 g/ml) and pON249 (2 g/ml) plasmids, and then luciferase and ␤-galactosidase activities were measured. The ratio between luciferase values and ␤-galactosidase values was used to correct for differences in transfection efficiency.
Statistics
Data are expressed as the mean Ϯ sem. Differences between basal and poststimulated points were determined using a paired t test. P Ͻ 0.05 was considered statistically significant.
Results
Effects of testosterone on intracellular calcium in myotubes
Fluo-3 fluorescence changes in intracellular Ca 2ϩ induced by testosterone (10 and 100 nm) were recorded. At 10 nm hormone, approximately 40% of the cells responded (11 of 27 cells), whereas at 100 nm testosterone, approximately 70% of the cells (101 of 139 cells, from 39 different cultures), responded to the hormone with an increase in intracellular calcium. The latter concentration was routinely used in all subsequent experiments. The effects of testosterone (100 nm) on intracellular calcium in myotubes are shown in Fig. 1A , which represents a sequence of fluorescence images acquired at the times indicated. The response was characterized by fast and transient increases (seconds to minutes) in the fluorescence of myotubes preloaded with fluo-3. Frequently, calcium oscillations and waves were observed (n ϭ 72 from 101 cells responding to testosterone). In this particular experiment, an increase in basal fluorescence after hormone exposition can be seen, and it is possible to note that fluorescence oscillates in certain regions of the myotube, producing a propagated calcium wave from one end to the center of the myotube. Rapid testosterone effects (within the first minute) involving second messengers have been reported in other cell types, and nongenomic mechanisms of signal transduction have been proposed (5, 29, 30) . To evaluate whether the effect of the hormone is mediated by extracellular membrane receptors, we tested the effect of testosterone covalently bound to albumin (T-BSA). This compound does not cross the plasma membrane, nor has it been reported to act on intracellular androgen receptors. T-BSA produces intracellular calcium increases in myotubes (Fig. 1, B and D) and this response is similar to that obtained with the free hormone. Albumin (0.1%) does not produce any change in the intracellular Ca 2ϩ (Fig. 1D) . When calcium signals produced by testosterone and T-BSA were compared, no differences were found in the onset of the signal (time to peak, 34 Ϯ 8 and 38 Ϯ 12 sec, respectively) or the maximal intracellular Ca 2ϩ response (84 Ϯ 22% and 88 Ϯ 20% with respect to basal fluorescence, respectively). For both hormones, the intracellular Ca 2ϩ oscillations diminish in fluorescence intensity over time and have a mean frequency of 0.083 Ϯ 0.029 Hz. To investigate whether other steroids produce similar responses, we used several known hormones. Nandrolone, a synthetic androgen, mimics the effects of testosterone ( Fig. 2A) , suggesting that the intracellular calcium increase is a common pathway for androgen steroid action in skeletal muscle cells. The response was specific to androgens, because the use of 17␤-estradiol, progesterone, or dexamethasone ( Fig. 2A) produced no detectable calcium rises.
If the intracellular androgen receptor were responsible for the androgen-triggered calcium increase in skeletal muscle cells, this increase should be blocked by cyproterone acetate, an antagonist of the intracellular androgen receptor. Cyproterone has been shown to block genomic activation in a number of cell systems (31) . However, the intracellular Ca 2ϩ transient triggered by either testosterone or nandrolone (n ϭ 22 and n ϭ 16, respectively) was not affected by pretreating the myotubes with a high concentration (1 m) of cyproterone acetate for 30 min (Fig. 2B) . Furthermore, the intracellular androgen receptor translocation from the cytoplasm to nucleus upon hormone binding is necessary for its activation and subsequent action on transcriptional machinery (32) . To determine whether this critical step occurs within the time frame in which testosterone-induced Ca 2ϩ increases are produced, immunocytochemistry was used to locate the intracellular androgen receptor in control myotubes and after testosterone stimulation at different times. Figure 3A shows the cytoplasmic location of androgen receptors in a control myotube (no stimulus). After incubation for 5 min with 100
FIG. 2. Effects of different steroids on calcium signals in myotubes.
Intracellular Ca 2ϩ is expressed as a percentage of the fluorescence intensity relative to the basal value. A, Time course of steroid-induced intracellular calcium increases. The figure shows a representative experiment in a myotube stimulated with nandrolone (f; 100 nM). The calcium increase reached 50-fold the basal value, and some oscillations were present (n ϭ 32 cells in 16 independent experiments). Other steroid hormones, 17␤-estradiol (Ⅺ; 1 M), progesterone (OE; 1 M), and dexamethasone (E; 100 nM), did not show an effect on the intracellular calcium concentration over the time period studied. B, Myotubes were pretreated with 1 M cyproterone (an antagonist of intracellular androgen receptor) and then stimulated with testosterone (F; 100 nM), nandrolone (Ⅺ; 100 nM), or vehicle (E; Ͻ0.01% ethanol). Cyproterone did not modify the androgen-evoked intracellular calcium increases. The time of addition of the hormone is indicated (arrows). nm testosterone, the intracellular distribution was similar to that under control conditions (Fig. 3B) , and only after 60 min of testosterone addition was receptor translocation to the nuclear compartment observed (Fig. 3C ). This time is far larger than that required to produce effects on intracellular Ca 2ϩ . To confirm that the dose of cyproterone used was able to inhibit androgen receptor translocation, myotubes were incubated with 1 m of the antagonist for 30 min before testosterone stimulation. Figure 3D shows that cyproterone alone did not affect the cytosolic localization of androgen receptors and largely inhibited the testosterone-induced nuclear translocation normally seen after 1 and 2 h (Fig. 3, E and F, respectively), indicating that this concentration of cyproterone was effective in inhibiting the genomic effects of the hormone. Collectively, these results indicate that intracellular androgen receptors are not involved in the testosteroneinduced intracellular Ca 2ϩ increases in myotubes. The extra-or intracellular origin of the calcium involved in these signals was investigated using a variety of experimental conditions. First, myotubes were incubated in a virtually Ca 2ϩ -free medium (1 mm EGTA) previous to androgen stimulation, and the sustained calcium increase was still present (n ϭ 18; Fig. 4A ). Interestingly, under these conditions, the intracellular Ca 2ϩ oscillations were completely lost in most experiments. Furthermore, nifedipine (10 m), an inhibitor of L-type voltage-gated calcium channels, did not modify the Ca 2ϩ oscillations induced by testosterone (data not shown). Thus, androgen-induced calcium increases as well as the Ca 2ϩ oscillations must originate from intracellular calcium stores.
To identify the calcium release systems involved in these signals, we pharmacologically altered IP 3 -mediated processes. Calcium signals evoked by testosterone were almost completely blocked in 15 of 19 experiments by use of 10 m U-73122, a phospholipase C (PLC) inhibitor, and in 14 of 14 experiments by use of 40 m xestospongin B, a blocker of IP 3 receptors (Fig. 4A) . Pretreatment of myotubes with ryanodine (20 m) did not modify the calcium response (data not shown), suggesting that IP 3 is involved in the androgeninduced intracellular calcium release in myotubes. To further probe this point, we measured IP 3 mass in response to androgen. Figure 4B shows the time course of both testosterone and nandrolone effects on IP 3 mass in cultured myotubes. The basal value of IP 3 mass increased significantly after 30 sec of hormone exposure and reached a maximum 45 sec after hormone addition for both steroids. The IP 3 mass then gradually returned to its basal value. The increase in IP 3 mass preceded the fast oscillatory calcium transient (see Fig. 1A ). Furthermore, neither the basal value of IP 3 mass nor the increased mass in response to testosterone were significantly affected when myotubes were incubated for 30 min with 1 m cyproterone (basal, 47.3 Ϯ 10.2 vs. 58.2 Ϯ 8.5 pg/mg protein; post stimuli, 140.6 Ϯ 5.2 vs. 138.1 Ϯ 10.1 pg/mg protein).
To determine the early events involved in the Ca 2ϩ signal produced by testosterone, myotubes were incubated for 20 min with 50 m genistein, a tyrosine kinase inhibitor, previous to hormone stimulation. This inhibitor did not modify the testosterone-induced intracellular Ca 2ϩ increases (Fig. 5A) . On the other hand, a role for a G protein in this effect was evaluated. Myotubes were permeabilized for 5 min with saponin in the presence of 100 nm GDP␤S, a nonhydrolyzable analog of GTP. Permeabilization did not modify testosterone-induced responses in the myotubes, whereas GDP␤S suppressed the Ca 2ϩ increases induced by the hormone (Fig. 5B) . Furthermore, myotubes were incubated with PTX (1 g/ml) before testosterone stimulation. Figure 5C shows that PTX inhibited the Ca 2ϩ signals produced by the hormone. A similar effect of these inhibitors was observed when the IP 3 mass was analyzed; genistein did not affect the testosterone-induced IP 3 increase, whereas both GDP␤S and PTX almost totally blocked this increase (Fig. 5D) . These results suggest that testosterone action requires a PTXsensitive G protein to produce both the intracellular IP 3 and Ca 2ϩ increases in myotubes.
Effects of androgen steroids on phosphorylation of ERK1/2
ERK1/2 was assessed in cultured myotubes using an antibody to phosphorylated Thr 202 and Tyr 204 . The dual phosphorylation of ERK1/2 represents a measurement of the enzyme activity (13, 14) . Stimulation of skeletal muscle cells with testosterone (100 nm) increased inmunodetectable dual phosphorylation of ERK1/2 within a few minutes (Fig. 6A) . Total-ERK1/2 staining (nonphosphorylated and phosphorylated ERK1 and -2 proteins) confirmed that within a particular experiment the individual lanes were loaded with equal amounts of proteins (Fig. 6B) . To evaluate the time course of ERK1/2 phosphorylation during androgen stimulation, myotubes were incubated with 100 nm testosterone or nandrolone for 1, 5, 15, 30, and 60 min (Fig. 6C) . Incubation of skeletal muscle cells with testosterone or nandrolone resulted in the dual phosphorylation of ERK1/2, as detected by Western blot, that can be detected after 1 min and significantly increased after 5 min for both hormones (Fig. 6A , lanes 2 and 3 for testosterone, lanes 5 and 6 for nandrolone; 1 and 5 min, respectively). Phosphorylation was fast and transient, and after 60 min of ERK1/2 phosphorylation returned to basal levels (Fig.  6A, line 4, and Fig. 6C ). The effect of nandrolone-induced ERK1/2 phosphorylation was similar to that induced by testosterone. Densitometric analysis showed that the androgen-induced phosphorylation at 5 min was 2.0-to 2.5-fold basal values (Fig. 6C) .
We further determined the concentration dependence of testosterone effects on ERK1/2 phosphorylation, myotubes were stimulated for 5 min with the hormone at different concentrations within the physiological range. In  Fig. 7A , the Western blot shows that the testosteroneinduced ERK1/2 phosphorylation in myotubes was dose dependent. Significant increases in phosphorylation were observed at a concentration of 10 nm testosterone. At 1 m testosterone, the response continued to increase (Fig. 7C) . We did not study concentrations above this range because they may not have physiological relevance and may be due to less specific effects. Furthermore, cyproterone was used in these experiments to test whether a classical genomic transcription-mediated pathway mediates the effect of androgen steroids on ERK1/2 phosphorylation. When cells were incubated with cyproterone acetate (1 m) for 30 min before the addition of testosterone or nandrolone, no effects on the basal phosphorylation of ERK1/2 were seen (Fig. 7D, first two columns) . Both testosterone and nandrolone stimulation for 5 min produced a rapid increase in ERK1/2 phosphorylation in cultured myotubes (Fig.  7D , third and fourth columns), indicating that this response was not dependent on an intracellular androgen receptor. Furthermore, T-BSA (100 nm) increased ERK1/2 phosphorylation, in a time scale similar to that of testosterone or nandrolone (Fig. 7D, last column) . These results indicate that ERK1/2 phosphorylation does not involve
FIG. 5. Effects of genistein, GDP␤S,
and PTX on testosterone-induced intracellular Ca 2ϩ and IP 3 increases. A, Myotubes were incubated for 20 min with 50 M genistein, a tyrosine kinase inhibitor, and then stimulated with testosterone (F; 100 nM). The use of genistein did not modify the Ca 2ϩ increases produced by the hormone. The vehicle ethanol (E; Ͻ0.01%) did not modify fluorescence during the times studied. B, Cells were permeabilized with saponin and stimulated with testosterone (f); note that in these conditions the cell did not lose the capacity to respond to the hormone. Nevertheless, permeabilization in the presence of GDP␤S (Ⅺ; 100 nM) blocked the testosterone-induced Ca 2ϩ increases. C, Myotubes were incubated with 1 g/ml PTX (‚; 1 g/ml) for 5 h and then stimulated with testosterone. PTX blocked the Ca 2ϩ increases induced by the hormone. D, Cells were incubated with PTX (1 g/ml for 5 h), GDP␤S (100 nM for 5 min) or genistein (gen; 50 M for 20 min) and then stimulated with testosterone (100 nM) for 45 sec. Both PTX and GDP␤S inhibited the IP 3 increases induced by testosterone. The IP 3 mass correspond to the mean Ϯ SEM of three experiments performed in triplicate. *, P Ͻ 0.05 compared with the control.
the intracellular androgen receptor and is probably mediated by interactions at the plasma membrane level.
Role of calcium in testosterone-induced ERK1/2 phosphorylation
To determine whether intracellular calcium is involved in ERK1/2 phosphorylation by testosterone, we designed two experiments. First, we examined whether ERK1/2 phosphorylation was dependent on calcium influx from extracellular medium. To this aim, myotubes were incubated for 5 min before experiments in nominally calcium-free medium (1 mm EGTA added). As shown in Fig. 8, A and B, ERK1/2 phosphorylation was about 26% lower in magnitude, but did not disappear. Second, we incubated the myotubes with BAPTA-AM, a compound that crosses the cell membrane and chelates intracellular calcium ions. As observed in Fig. 8, A and B, the testosterone-induced ERK1/2-phosphorylation in myotubes preincubated with BAPTA-AM was blocked. These observations suggest that an elevation of intracellular calcium is needed for ERK1/2 phosphorylation. To confirm the role of PLC as a mediator of intracellular calcium release and subsequent ERK1/2 phosphorylation, we used inhibitors of the IP 3 pathway. In myotubes preincubated with 10 m U73122 or 40 m xestospongin B, no effect on basal phosphorylation of ERK1/2 was evident; however, complete inhibition of testosterone-induced ERK1/2 phosphorylation was observed (Fig. 8C) . These results indicate that the calcium involved in ERK1/2 phosphorylation is released from intracellular stores after activation of PLC, IP 3 generation, and binding to IP 3 receptors. 6) for the times indicated. After incubation, cells were lysed, cytosolic protein (20 g) was resolved on 10% SDS-PAGE, and phosphorylated ERK1/2 was detected immunologically after transfer to polyvinylidene difluoride membranes. B, Equal loading of ERK1/2 proteins was verified by Western blot with total ERK antibodies. C, Time course of phosphorylation of ERK1/2 in the presence of 100 nM testosterone (F) or nandrolone (Ⅺ). ERK1/2 was normalized by referring to the total ERK1/2 and is expressed as a percentage with respect to basal phosphorylation. The values are the mean Ϯ SEM (n ϭ 4; for each point). *, P Ͻ 0.05.
FIG. 7.
Effects of testosterone and cyproterone on androgen-induced ERK1/2 phosphorylation in myotubes. A, Myotubes were stimulated with 1 nM, 10 nM, 100 nM, or 1 M testosterone for 5 min. B, Equivalent loading of total ERK1/2 proteins is shown. C, The band density of A is plotted as a function of the dose of testosterone. Quantification of band density is expressed as a percentage of the control value (set at 100%) from three independent experiments and is shown as the mean Ϯ SEM. *, P Ͻ 0.05 respect to control value. D,When indicated, myotubes were preincubated for 30 min with 1 M cyproterone, an antagonist of intracellular androgen receptor, and then stimulated with 100 nM testosterone, nandrolone, or T-BSA for 5 min. *, P Ͻ 0.05 vs. basal (n ϭ 4 for each point).
PTX effects on ERK phosphorylation induced by testosterone
To evaluate G protein participation in the ERK1/2 phosphorylation increases induced by testosterone, myotubes were permeabilized with saponin in the presence of 100 nm GDP␤S for 5 min. This procedure did not modify basal protein phosphorylation, but inhibited the increase in ERK1/2 phosphorylation induced by the testosterone (Fig. 9) . Similarly, the incubation of the myotubes with 1 g/ml PTX for 5 h before testosterone stimulation blocked the response to the hormone (Fig. 9) . These results suggest that testosteroneinduced ERK1/2 phosphorylation requires the participation of a PTX-sensitive G protein.
Roles of MEK and Ras protein in testosterone-induced phosphorylation of ERK1/2
ERK1/2 are activated by phosphorylation of threonine and tyrosine residues by the dual specific MEK (18) . To determine the role of MEK in the transient testosteroneinduced phosphorylation of ERK1/2, we used the compound PD 98059. This is a selective inhibitor of MEK activity, inhibiting the activation of ERK1/2 and the subsequent phosphorylation of ERK1/2 substrates both in vitro and in intact cells (16) . In Fig. 10A , results from myotubes incubated for 20 min with 10 m PD 98059 are shown. This compound almost completely blocked testosterone-induced ERK1/2 phosphorylation without an effect on the basal phosphorylation of this protein. The role of Ras in the signal transduction cascade mediated by androgens was also evaluated using dominant negatives for MEK and Ras proteins. Figure  10B shows a selective blockade of testosterone-induced ERK1/2 phosphorylation by dominant negatives for both MEK and Ras. These results are consistent with ERK1/2 phosphorylation induced by testosterone through the Ras/ MEK/ERK pathway in cultured myotubes.
Effect of testosterone on the transcription factor CRE-binding protein (CREB)
To further test cyproterone inhibition of genomic effects of testosterone, myotubes were transfected with a luciferase linked reporter gene for CRE. Transcription was activated by testosterone after 12 h (Fig. 11) , and the effect was completely blocked by cyproterone, indicating a genomic effect mediated by intracellular androgen receptors. Furthermore, tes- tosterone linked to BSA was not able to mimic this effect (Fig. 11) .
Discussion
We show here suggestive evidence of a G protein-linked membrane receptor activated by androgens in skeletal muscle cells. Furthermore, activation of this receptor results in both intracellular calcium transients and extracellular signalregulated kinases (ERK1/2) in cultured myotubes. Exposure of myotubes to either testosterone or nandrolone produced a calcium-dependent, early, but transient, ERK1/2 phosphorylation, which did not appear to be mediated through intracellular androgen receptors but by a G protein-coupled membrane receptor. Increases in androgen-induced phosphorylation are not inhibited by cyproterone, an antagonist of intracellular androgen receptors. Furthermore, testosterone bound to a large protein molecule (T-BSA) mimics these effects. Moreover, these steroid hormones induce an IP 3 -dependent intracellular calcium increase, which is required for ERK1/2 phosphorylation. These results indicate that the rapid responses triggered by both testosterone and nandrolone are not due to activation of the classical intracellular androgen receptor in myotubes.
The skeletal muscle cell is a target for androgen action (1, 20) . Binding of steroid hormones to intracellular receptors mediates a variety of genomic responses in this cell type (20, 21, 32) . However, several observations demonstrate that androgens also produce nonclassical effects, particularly, the activation of intracellular mechanisms of signal transduction (4, 5) . In myotubes we found that the time course analysis of the changes in Ca 2ϩ signals show that the calcium increase is fast and transient, occurring within seconds after the addition of either testosterone or its structural cognate nandrolone. Calcium increased at both the cytosolic and the nuclear level. As we are not using a ratiometric dye and as the dye may be compartmentalized, higher fluorescence in the nucleus does not necessarily mean a higher calcium concentration in this compartment; however, the nuclear component of the calcium signal was evident. Interestingly, we observed intracellular Ca 2ϩ oscillations, sometimes propagating as Ca 2ϩ waves along the myotubes. The generation of Ca 2ϩ waves may represent an important early step for the coordination of cell functions in skeletal muscle cells (10) . The increases in intracellular calcium have different spatial and temporal patterns, and release from different subcellular compartments influences the transcriptional response (10, 12) . Thus, a different oscillatory pattern may mean a different mechanism of calcium release and recapture as well as a different function for calcium as an intracellular signal.
Our data show that the Ca 2ϩ increase elicited by androgens is due to Ca 2ϩ released from intracellular stores. There is evidence that calcium signals evoked by stimulation of myotubes with androgens involve the formation of IP 3 (6) . This is probably due to activation of phospholipase C, because the responses are produced in Ca 2ϩ -free medium, and inhibitors of the IP 3 -mediated pathway almost completely blocked the calcium increases in response to testosterone. Moreover, increases in IP 3 mass precede the oscillatory calcium transients, suggesting a sequential relationship between IP 3 increases and Ca 2ϩ increases. Interestingly, these oscillations are not observed in calcium-free medium. In many cell types, depletion of calcium from intracellular stores is followed by an influx of calcium from the extracellular space through activation of store-operated channels (33); thus, androgen-evoked Ca 2ϩ oscillations in myotubes may involve interactions between events in the plasma membrane and internal stores, with calcium release from sarcoplasmic reticulum being a key event for this mechanism. It 6) . C, Equal proteins loads were verified using antibodies directed against total ERK1/2 (n ϭ 4 for each point).
has been proposed that the generation and propagation of intracellular Ca 2ϩ oscillations may reduce the thresholds for action of this second messenger, and different Ca 2ϩ oscillatory patterns can preferentially activate or inactivate calcium-dependent processes (34).
Testosterone exerts its effects through binding to and activation of cytosolic androgen receptor, which translocates to the nucleus and functions as a transcription factor (3, 30) . In our system cyproterone, an antagonist of the intracellular androgen receptor was able to block both the receptor translocation and CRE-mediated transcription, events probably mediated by the intracellular androgen receptor. Nevertheless, androgen-induced second messenger generation was not blunted by cyproterone, and the membrane-impermeant testosterone conjugate (T-BSA) induced similar effects on calcium compared with the free hormone, suggesting that these rapid effects are mediated by the actions of androgens on membrane components. The IP 3 -mediated calcium release from internal stores can be due to activation of tyrosine kinase as well as G protein-coupled membrane receptors. The treatment of myotubes with genistein, a tyrosine kinase inhibitor, did not modify the intracellular Ca 2ϩ or IP 3 increases induced by testosterone. On the other hand, several lines of evidence demonstrate that androgens can activate PTX-sensitive G proteins (5, 35) ; to determine whether testosterone may interact with a G proteins in myotubes, the Ca 2ϩ increase was evaluated in myotubes treated with GDP␤S and PTX. The fact that G protein inhibitors blocked fast effects of testosterone reinforces the idea of a membrane receptor for this hormone. The presence of membrane binding sites for androgens has been previously suggested (4, 5, 29) . According to our results in myotubes, testosteroneinduced intracellular calcium increases have also been described in other cells, including rat osteoblasts (4), mice splenic T cells (29) , and macrophages (5). Interestingly, macrophages, lacking classical intracellular androgen receptors, respond to testosterone with intracellular Ca 2ϩ increases. Thus, a transient increase in calcium should affect certain cellular processes directly (nongenomic pathway), or alternatively, they could act through Ca 2ϩ -binding proteins to regulate slower processes (genomic pathway) via protein synthesis.
Steroid hormones have been associated with the growth and differentiation of muscle cells, but to date little evidence has accumulated on the role of intracellular signaling pathways in these processes. Upon activation by phosphorylation, ERK1/2 translocate from the cytoplasm into the nucleus (14) , and this results in the phosphorylation or induction of transcription factors, leading to the expression of genes involved in the control of cellular growth. The results reported here show that testosterone, nandrolone, and T-BSA can induce dual phosphorylation of ERK1/2 within a few minutes. In skeletal muscle an increase in the ERK1/2 phosphorylation correlates with its activity (15, 19) . The rapid phosphorylation of ERK1/2 by androgens was transient and dose dependent, demonstrating that myotubes respond to testosterone in the physiological range of concentrations. The relationship among intracellular calcium increases, the IP 3 pathway, and ERK1/2 phosphorylation was illustrated by pharmacologically manipulating the calcium sources. Thus, testosterone-induced ERK1/2 phosphorylation was slightly inhibited in a nominally Ca 2ϩ -free medium, a possible explanation being that the effect of intracellular Ca 2ϩ increases depends on the time course, i.e. ERK1/2 phosphorylation will be different depending on whether the calcium increase occurs with an oscillatory pattern or not. A similar effect has been suggested for the effects of ouabain, a steroid derivative, on the transcription factor nuclear factor-B, which reaches maximal activation during calcium oscillations, but not during maintained Ca 2ϩ increase (36) . On the other hand, steroid-induced ERK1/2 phosphorylation was completely blocked by chelation of intracellular calcium with BAPTA-AM or the use of either U-73122, a PLC inhibitor, or xestospongin B, an inhibitor of IP 3 receptors. Moreover, G protein-coupled receptors can induce ERK1/2 activation (13, 14) . Testosterone-induced ERK1/2 phosphorylation in the myotubes was inhibited by treatment with GDP␤S and PTX, suggesting the participation of a PTX-sensitive G protein in this response. These results are in accordance with the inhibition of intracellular Ca 2ϩ and IP 3 increases by the G protein inhibitors and the Ca 2ϩ requirement for the ERK1/2 phosphorylation induced by testosterone in myotubes.
Some researchers have shown that antagonists for intracellular receptors can block steroid-induced ERK1/2 phosphorylation (37) . However, after incubation of myotubes with 1 m cyproterone in the present study, neither basal ERK1/2 phosphorylation nor testosterone-dependent phosphorylation was modified. Even though these effects were not blocked by cyproterone in skeletal muscle cells, which suggests that activation of the transcription machinery was not involved, nongenomic effects may play a physiological role in events previous to the androgen receptor activation. A likely possibility is phosphorylation of coactivators that amplify the androgen action, as has been proposed by Zhu et al. (38) , or a biphasic system with both high affinity nuclear as well as low affinity membrane androgen receptors, as described in rat Sertoli and human prostatic cell lines (39) . Several mitogens can produce trans-activation of steroid receptors through phosphorylation (40, 41 ). An interesting hypothesis to be explored is that intracellular calcium increases and ERK1/2 activation are events that elicit androgen receptor activation in skeletal muscle cells. Moreover, the MAPK cascade triggered by the binding of hormones or growth factors to surface receptors may produce the phosphorylation events that have been implicated in cell growth and differentiation (18) . Gredinger et al. (16) have shown that the MAPK pathway plays a positive role in myogenesis and that ERK activity is substantially increased during terminal muscle differentiation in muscle cells and cooperates with MyoD to activate muscle-specific transcription. In accordance with the rapid effects of steroid hormones, Morelli et al. (23) have recently shown that 1,25-dihydroxyvitamin D 3 activates ERK1/2 in skeletal muscle cells and has implicated the MAPK cascade in hormone control of myoblast proliferation. ERK1/2 are activated by phosphorylation of both threonine and tyrosine residues; these reactions are catalyzed by MEK. MEK itself is activated by at least two types of kinases, Raf-1 and MEK kinase (13, 14, 18) . Raf-1, which is also activated by phosphorylation, appears to be a central point in receiving signals from upstream activated kinases, located at the plasma membrane. Most of the signaling pathways that have been proposed to be involved in the activation of ERK1/2 after increasing intracellular Ca 2ϩ converge on Ras, thus indicating a key role for this protein in this process (14, 18) . The observations that overexpression of dominant negative mutants of Ras and MEK inhibits testosterone-mediated ERK1/2 phosphorylation reflects that this hormone activates the Ras/MEK/ERK pathway in myotubes. The mechanism of Ca 2ϩ -mediated Ras activation remains elusive; however, in other cell types, a Ras-dependent activation of ERK1/2 by either PKC (18) or Ca 2ϩ -regulated protein kinase such as calmodulin (12) has been described. Buitrago et al. (42) recently demonstrated in avian myotubes that 1␣,25-dihydroxyvitamin D 3 -induced MAPK activation occurs through both a Raf-1 via Ras pathway as well as a PKC␣-dependent pathway. The intracellular targets for the steroid-stimulated ERK1/2 cascade have not been established. It has been reported that androgens can activate the transcription factor CREB (43) . However, in myotubes the transcriptional CREB activity induced by testosterone, but not by T-BSA, indicates that a hormone-bound intracellular androgen receptor is necessary for this effect. There is evidence that activation of several signaling pathways involving protein kinase A and C leads to stimulation of androgenregulated trans-activation through interaction of components of these pathways with the androgen receptor (41). It is possible, then, that the interaction of activated androgen receptor with some of the signaling pathways will eventually lead to activation of the element-binding protein by phosphorylation (43) . A possible role for the ERK pathway would be to phosphorylate hormone-bound androgen receptors (44) and modulate transcriptional activity (22, 30) . Another possibility could be that ERK-activated pathways could influence the genomic response through a synergistic mechanism by phosphorylation of coactivators of the intracellular receptor at the nuclear level, as reported for both thyroid receptor and estrogen receptor (45, 46) . A scheme of the proposed G protein-dependent action for androgens in skeletal muscle cells is depicted (Fig. 12) . It includes a putative membrane androgen receptor coupled to PTX-sensitive G protein, PLC activation, and calcium release; ERK1/2 phosphorylation appears to be triggered by calcium. Taken together, our results indicate that increases in intracellular calcium as well as activation of the Ras/MEK/ ERK1/2 pathway represent an intermediate step in the intracellular signaling toward as yet undefined downstream effects of androgen steroids on skeletal muscle cells.
FIG. 12.
Scheme for the fast effects of testosterone in myotubes. PLC activation, through a putative membrane androgen receptor (AR) coupled to a PTX-sensitive G protein, increases IP 3 levels, which, in turn, produces intracellular Ca 2ϩ increases. This increase in cytosolic calcium may be through a Ca 2ϩ -dependent protein kinase; it can regulate Ras activity at the plasma membrane level and will initiate a signaling cascade leading to ERK1/2 phosphorylation.
